MEDVi tirzepatide: price, structure, and position (2026)
MEDVi↗ charges $399 a month all-in for compounded tirzepatide at the 10 mg maintenance basis — dose-flat across the entire ladder, with no membership fee — ranking #14 of 17 verified programs (captured 2026-08-05).
Updated 2026-08-10 · figures captured 2026-08-09 · how we verify
SOURCE-VERIFIED · captured 2026-08-05 · source · archive
What MEDVi bills for tirzepatide, exactly
On tirzepatide, the number that matters at MEDVi is $399 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. Because pricing is flat across the ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)), a dose increase at MEDVi is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.
There is no membership line. $399 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.
Context for that figure: it ranks #14 of 17 in the verified tirzepatide index — $184/month above the floor (NexLife↗, $215) — and sits $50 under the brand benchmark (Zepbound (LillyDirect↗), $449 at maintenance). Annualized, a monthly-billed year here runs $4,788.
Tirzepatide, across time
Time is the axis marketing hopes you skip, so here it is:
1 month: $399 billed monthly. 3 months: $1,197 billed monthly; no prepaid term is published at this horizon, so monthly billing is the only path. 6 months: $2,394 billed monthly; no prepaid term is published at this horizon, so monthly billing is the only path. 9 months: $3,591 billed monthly; no prepaid term is published at this horizon, so monthly billing is the only path. 12 months: $4,788 billed monthly; no prepaid term is published at this horizon, so monthly billing is the only path. 18 months: $7,182 billed monthly; no prepaid term is published at this horizon, so monthly billing is the only path. 24 months: $9,576 billed monthly; no prepaid term is published at this horizon, so monthly billing is the only path.
Remember what the arithmetic cannot know: whether you will tolerate the medication, whether the dose will move (financially irrelevant here, since pricing is flat), and whether the program’s terms will hold. The calculator reruns all of this at your inputs.
Where this price sits — tirzepatide
In the tirzepatide index, MEDVi ranks #14 of 17 verified programs — $184 a month above the floor (NexLife, $215) and $198 under the ceiling (LifeMD↗, $597). One rung cheaper sits Fridays at $359 — a $40 monthly gap, $480 across a year — the head-to-head is at MEDVi vs Fridays. One rung pricier is Remedy Meds↗ at $399 (+$0/month); that comparison lives at MEDVi vs Remedy Meds. Against the approved product: Zepbound (LillyDirect) runs $449 at maintenance, so MEDVi is $50 a month ($600/year) under brand; note the maintenance figure holds only with refills inside Lilly’s 45-day window.
Against the five nearest rivals — tirzepatide
Remedy Meds is priced identically at $399 (no membership, dose-flat). Eden costs $9 more a month ($108/year) at $408 ($99/mo membership inside its figure, tiered/step structure). Fridays costs $40 less a month ($480/year) at $359 (no membership, dose-flat). Lavender Sky Health costs $47 less a month ($564/year) at $352 ($25/mo membership inside its figure, tiered/step structure). Henry Meds costs $50 less a month ($600/year) at $349 (no membership, dose-flat).
Operationally: Shipping is included, so the door-to-door figure is the advertised figure; the clinical consultation is included rather than billed separately; labs are not required to enroll (a prescriber can still order them for cause, which is medicine, not upsell); the visit model is async. Commitment: 12-month plan for the lowest rate; cancellation: 12-month plan applies to lowest rate. Fulfillment is the weak point of the record: the pharmacy is not publicly named beyond “not named”, so the license-checking a careful buyer would do is not possible from the outside. Ask during intake, in writing, before paying.
Where these numbers come from: source-verified, last read 2026-08-05 from the provider’s published pages, archived at capture. Every figure above traces to a dated capture; when the provider’s page changes, the database changes, and the diff lands in the changelog. If any number here no longer matches what MEDVi publishes, tell the desk — confirmed errors are fixed sitewide in one rebuild and logged permanently.
Frequently asked
Is MEDVi good for tirzepatide?
MEDVi charges $399 a month all-in for compounded tirzepatide at the 10 mg maintenance basis — dose-flat across the entire ladder, with no membership fee — ranking #14 of 17 verified programs (captured 2026-08-05). Whether the structure fits you — flat pricing rewards anyone titrating upward — is the real question, and the sections below lay out the mechanics.
How does MEDVi compare to the cheapest tirzepatide program?
The verified floor is NexLife at $215/month — $184/month ($2,208/year) below MEDVi. The full ladder: cheapest tirzepatide providers.
Where do these MEDVi tirzepatide numbers come from?
From the provider’s own published pages, captured 2026-08-05 (source-verified), normalized to the all-in 10 mg basis, archived, and regenerated on every dataset change — the record and its source links live in the price database.